Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases(MT201-204) | completed | Phase 2 | 35 | Amgen Research (Munich) GmbHINDUSTRY | 2 | Nov 11, 2011 | clinicaltrials |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00668863 | Study Of Sunitinib With FOLFIRI In Colorectal Cancer | completed | Phase 2 | 71 | PfizerINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT00345696 | 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR. | completed | Phase 2 | 32 | Unidad Integral de Investigación en Oncología S.L.OTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00497263 | End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study | completed | Phase 2 | — | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00809796 | A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment | completed | Phase 1 / Phase 2 | 15 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00004087 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | completed | Phase 1 / Phase 2 | 48 | CTI BioPharmaINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00827684 | Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations(TIRASMUS) | completed | Phase 2 | 50 | Vejle HospitalOTHER | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00083720 | Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy | completed | Phase 2 | 87 | Eli Lilly and CompanyINDUSTRY | 2 | May 25, 2011 | clinicaltrials |
| NCT00544349 | Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery | completed | Phase 2 | 45 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 80 | Institut Cancerologie de l'OuestOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00193167 | Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00166465 | Stage IV Colorectal CA ALIMTA | completed | Phase 1 / Phase 2 | 200 | Mayo ClinicOTHER | 1 | Mar 14, 2011 | clinicaltrials |
| NCT00118755 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 435 | Hoffmann-La RocheINDUSTRY | 0 | Mar 3, 2011 | clinicaltrials |
| NCT00044863 | Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma | completed | Phase 2 | 250 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00224601 | CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 18, 2011 | clinicaltrials |
| NCT00232453 | Preoperative Combined Radiation and Chemotherapy - Rectal Cancer | completed | Phase 2 | 34 | University Health Network, TorontoOTHER | 1 | Feb 15, 2011 | clinicaltrials |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00113776 | Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT01262417 | Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation(SEPRAC2T) | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00228189 | Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Radboud University Medical CenterOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00386828 | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | completed | Phase 2 | 43 | British Columbia Cancer AgencyOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00254137 | Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 92 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT01212718 | Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase(FOGT5) | completed | Phase 2 | 168 | University of UlmOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00403624 | Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer | completed | Phase 1 / Phase 2 | 38 | SanofiINDUSTRY | 0 | Aug 27, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00188565 | Celebrex With Preoperative Chemoradiation - Rectal Cancer | completed | Phase 1 / Phase 2 | 39 | University Health Network, TorontoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT01177371 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT01152710 | Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer | completed | Phase 2 | 57 | Institute of Oncology LjubljanaOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00005981 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00671996 | Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C(MANFOL) | completed | Phase 2 | 14 | Egetis TherapeuticsINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT00055419 | A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer | completed | Phase 2 | 744 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT01024504 | Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00005804 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT01086683 | Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course | completed | Phase 2 / Phase 3 | 513 | Danish Cancer SocietyOTHER | 1 | Mar 15, 2010 | clinicaltrials |
| NCT00285701 | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | completed | Phase 1 / Phase 2 | 38 | PhotocureINDUSTRY | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00220116 | Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer | completed | Phase 2 | 172 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00220155 | Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 16 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00174616 | CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision | completed | Phase 2 | 87 | SanofiINDUSTRY | 7 | Dec 7, 2009 | clinicaltrials |
| NCT00020930 | Cetuximab in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 4, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Nov 11, 2011source: clinicaltrials